Showing promise in the landscape of weight management therapy, retatrutide is a different strategy. Unlike many available medications, retatrutide operates as a twin agonist, concurrently targeting both glucagon-like peptide-1 (GLP-1) and glucose-sensitive insulinotropic substance (GIP) sensors. This simultaneous activation fosters various helpful … Read More